Table 2:
Stratification of mice into five treatment groups and evaluation of responses to therapy, toxicity, and recurrence. CR: complete response meaning no evidence of the tumor mass. PR: partial response meaning a decrease in tumor volume (≥25%). NR: no response meaning no significant decrease in tumor mass. Recurrence: increase in tumor mass after a complete or partial response. * Drug-related observable toxicity during treatment: More than 10% weight loss in a week or more than 20% weight loss over any time period; diarrhea, bulky ascites, distended abdomen, or lethargy.
Group | Treatment | Mice/group | CR | PR | NR | Treatment-Related Toxicity* | Recurrence |
---|---|---|---|---|---|---|---|
G1 | Vehicle control | 5 | 0 | 0 | 5 | 0 | N/A |
G2 | Cisplatin+ Paclitaxel 5 + 15 (mg/kg) | 5 | 0 | 0 | 5 | 0 | N/A |
G3 | Irinotecan 40 (mg/kg) | 5 | 1 | 3 | 1 | 0 | 3 |
G4 | Irinotecan 80 (mg/kg) | 5 | 3 | 2 | 0 | 3 | 2 |
G5 | ASC-shCE2:nLuc + Irinotecan 40 (mg/kg) | 5 | 4 | 1 | 0 | 0 | 1 |